BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
-
Russia's Max: The unencrypted super-app being forced on citizens
-
EU chief in Australia with eyes on trade deal
-
Asia champions Japan need 'different tools' to win World Cup - coach
-
Global economy under 'major threat' from Strait of Hormuz crisis: IEA chief
-
Planet trapped record heat in 2025: UN
-
Israel launches new strikes on Tehran as Iran takes aim at Gulf sites
-
German court to rule in climate case against automakers
-
France's leftists win mayoral elections in largest cities
-
Asian stocks tumble as Trump gives Iran 48-hour ultimatum
-
Wolves rally past Celtics, Nuggets sink Blazers
-
Middle East war to dominate Houston's 'Davos of Energy'
-
Kim holds off Korda charge to win LPGA Founders Cup
-
Trump orders immigration agents to airports amid crippling budget standoff
-
Iran awaits Trump threat to blow up power plants
-
Alcaraz eyes clay court season after early Miami exit
-
Real Madrid down Atletico in derby, leaders Barca edge Rayo
-
Korda sends Alcaraz to another early exit in Miami
-
Bordeaux-Begles hammer Toulouse in Dupont absence
-
Slovenia PM claims election win as results show neck and neck finish
-
England's Fitzpatrick birdies 18th to win PGA Valspar title
-
Man City's League Cup glory adds twist to title race
-
Leftists win mayoral elections in Paris and Marseille
-
Vinicius double helps Real Madrid edge Atletico thriller
-
Doncic cleared to face Pistons after foul rescinded: NBA
-
Inter's Serie A lead cut to six with Fiorentina draw, Como march on
-
World No.1 Alcaraz beaten by Korda in Miami Open third round
-
Cuba starts to restore power after new blackout
-
Ovechkin nets 1,000th combined NHL season-playoffs goal
-
Undav doubles up as Stuttgart down Augsburg to go third
-
Leftists win mayoral elections in Paris and Marseille: projections
-
Israel warns weeks of fighting ahead in Mideast war
-
Guardiola revels in Man City's 'special' League Cup win over Arsenal
-
Hodgkinson headlines Britain's 'Super Sunday' at world indoors
-
Messi scores for Miami in 3-2 MLS victory at NYCFC
-
Bezzecchi wins second race of the season at Brazil MotoGP
-
Britain's Hodgkinson wins world indoor 800m gold
-
Former France and West Ham star Payet announces retirement
-
Man City's O'Reilly savours 'unbelievable' double in League Cup final win
-
Israel to advance ground operations in Lebanon after striking key bridge
-
Man City win League Cup as O'Reilly sinks Arsenal after Kepa blunder
-
Marseille downed by Lille in Ligue 1 as Lyon's struggles continue
-
NBA bans Mitchell, Champagnie one game for sparking melee
-
'Project Hail Mary' rockets to top of N. America box office
-
Syrians protest alcohol sale limits, curbs on personal freedom
-
Spurs can '100 percent' avoid nightmare of relegation: Saltor
-
Araujo header scrapes Liga leaders Barcelona win over Rayo
-
Israel launches strikes as Lebanon warns of invasion
-
Torrential rains in Kenya kill 81 in March: officials
-
Iran threatens Mideast infrastructure after Trump ultimatum
-
Spurs felled by Forest in relegation battle, Sunderland shock Newcastle
BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
WESTMINSTER, CA / ACCESS Newswire / November 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Friday, November 14th, 2025, at 1:30 pm Pacific / 4:30 pm Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months ending September 30th, 2025, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
Webcast Link: | |
Teleconference Domestic: | 877-545-0320 |
Teleconference International: Participant Access Code: | +1-973-528-0002 517720 |
To watch or listen to a replay of the webcast or teleconference:
Teleconference Replay Expiration: | Sunday, February 14th, 2027 |
Teleconference Replay Domestic: | 877-481-4010 |
Teleconference Replay International: | 919-882-2331 |
Replay Passcode: | 53245 |
The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
D.Lopez--AT
